Gilteritinib or chemotherapy for relapsed or refractory FLT3-mutated AML: New England Journal of Medicine

AE Perl, G Martinelli, JE Cortes, A Neubauer, E Berman, S Paolini, P Montesinos, MR Baer, RA Larson, C Ustun, F Fabbiano, HP Erba, A Di Stasi, R Stuart, R Olin, M Kasner, F Ciceri, WC Chou, N Podoltsev, C RecherH Yokoyama, N Hosono, SS Yoon, JH Lee, T Pardee, AT Fathi, C Liu, N Hasabou, X Liu, E Bahceci, MJ Levis

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Gilteritinib or chemotherapy for relapsed or refractory FLT3-mutated AML: New England Journal of Medicine'. Together they form a unique fingerprint.

Medicine & Life Sciences